Novavax Inc. Q3 Loss decreases, but misses estimates

Novavax Inc. (NVAX) reported Loss for third quarter that decreased from the same period last year but missed the Street estimates.

The company's bottom line came in at -$168.61 million, or -$2.15 per share. This compares with -$322.43 million, or -$4.31 per share, in last year's third quarter.

Analysts on average had expected the company to earn $1.57 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 310.7% to $734.58 million from $178.84 million last year.

Novavax Inc. earnings at a glance (GAAP) :

-Earnings (Q3): -$168.61 Mln. vs. -$322.43 Mln. last year.
-EPS (Q3): -$2.15 vs. -$4.31 last year.
-Analyst Estimates: $1.57
-Revenue (Q3): $734.58 Mln vs. $178.84 Mln last year.

Full year revenue guidance: $2.0 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT